With a central focus on the full spectrum of nonsurgical and minimally invasive aesthetic treatments, as well as practice management and marketing, the TAS Advisory Board will give priority consideration to:

• Original ideas
• Progressive topics
• Cutting-edge abstracts and clinical research findings
• Nonsurgical & minimally invasive treatments and techniques

All abstracts are reviewed by members of our Scientific Advisory Board, and rated on a scale of 1-5 (5 being the highest), considering the following principles:

• Uniqueness and/or innovativeness of the topic/content
• Clear and consequential learning outcomes
• Completeness of information and ideas provided
• Clear explanation of its existing or impending impact and implications on the practice of aesthetic surgery and/or medicine
  • Incomplete Abstracts will not be reviewed or considered
  • There is a limit of 5 abstracts per Submitter and per parent company.

If you have questions about the submission process, please email faculty@aestheticshow.com.